Xizhi Wen

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 59 篇 · 总被引 1084 次 · h-index 17

代表论文

• Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma (2023 · Cell Reports Medicine · 被引 53)
• Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population–based analysis (2022 · Frontiers in Immunology · 被引 33)
• Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study (2022 · Frontiers in Immunology · 被引 29)
• HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma (2022 · Frontiers in Immunology · 被引 19)
• Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy (2022 · Scientific Reports · 被引 17)
• A pilot study of lymphodepletion intensity for peripheral blood mononuclear cell-derived neoantigen-specific CD8 + T cell therapy in patients with advanced solid tumors (2023 · Nature Communications · 被引 11)